Literature DB >> 17070998

Natural history of pain following herpes zoster.

Hans Gustav Thyregod1, Michael C Rowbotham, Michelle Peters, Jessica Possehn, Marlene Berro, Karin Lottrup Petersen.   

Abstract

In a longitudinal observational study of 94 patients (39 M:55 F, mean age 69) at elevated risk for developing post herpetic neuralgia (PHN), the natural history of pain during the first 6 months after herpes zoster (HZ) rash onset was determined. Pain severity and impact were rated using pain-VAS, SF-MPQ, and MPI. Applying a definition of PHN of average daily pain >0/100 on the pain VAS during the last 48 h, 30 subjects had PHN at 6 months. These 30 subjects reported more pain and a higher SF-MPQ score (p<0.01) at study inclusion than the 64 subjects whose pain completely resolved by 6 months. At 6 months, mean daily pain in the PHN group was 11/100 (95% CI 5,16) and only nine of these subjects were still taking prescription medication for HZ pain. The rate of recovery (pain severity over time) was the same in the PHN and no-pain groups. At study inclusion, the SF-MPQ and MPI scores in our PHN group were similar to historical controls with chronic severe PHN enrolled in clinical trials, but by 6 months the scores in our PHN subjects were significantly lower than historic controls. Only two subjects met the more stringent criteria for 'clinically meaningful' PHN at 6 months (> or = 30/100 on the pain VAS). Defining PHN as average daily pain >0/100 at 6 months after rash onset appears to substantially overestimate the number of HZ patients negatively impacted by ongoing pain and disability.

Entities:  

Mesh:

Year:  2006        PMID: 17070998      PMCID: PMC1905461          DOI: 10.1016/j.pain.2006.09.021

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  44 in total

1.  Phase specific analysis of herpes zoster associated pain data: a new statistical approach.

Authors:  R B Arani; S J Soong; H L Weiss; M J Wood; P A Fiddian; J W Gnann; R Whitley
Journal:  Stat Med       Date:  2001-08-30       Impact factor: 2.373

Review 2.  Zoster-associated pain and neural dysfunction.

Authors:  Michael C Rowbotham; Karin L Petersen
Journal:  Pain       Date:  2001-07       Impact factor: 6.961

3.  Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial.

Authors:  S N Raja; J A Haythornthwaite; M Pappagallo; M R Clark; T G Travison; S Sabeen; R M Royall; M B Max
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

4.  Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia.

Authors:  Elna M Nagasako; Robert W Johnson; David R J Griffin; Robert H Dworkin
Journal:  J Am Acad Dermatol       Date:  2002-06       Impact factor: 11.527

Review 5.  Understanding pain in herpes zoster: an essential for optimizing treatment.

Authors:  Martin Wood
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

Review 6.  Herpes zoster--predicting and minimizing the impact of post-herpetic neuralgia.

Authors:  R Johnson
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

7.  Oral opioid therapy for chronic peripheral and central neuropathic pain.

Authors:  Michael C Rowbotham; Lisa Twilling; Pamela S Davies; Lori Reisner; Kirk Taylor; David Mohr
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

8.  Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up.

Authors:  S Helgason; G Petursson; S Gudmundsson; J A Sigurdsson
Journal:  BMJ       Date:  2000-09-30

9.  Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia.

Authors:  M Haanpää; P Laippala; T Nurmikko
Journal:  J Pain Symptom Manage       Date:  2000-07       Impact factor: 3.612

10.  Clinical applications for change-point analysis of herpes zoster pain.

Authors:  Renee A Desmond; Heidi L Weiss; Ramin B Arani; Seng-jaw Soong; Martin J Wood; Paul A Fiddian; John W Gnann; Richard J Whitley
Journal:  J Pain Symptom Manage       Date:  2002-06       Impact factor: 3.612

View more
  19 in total

Review 1.  Postherpetic neuralgia #272.

Authors:  Shannon Ryan-Cebula; Hunter Groninger
Journal:  J Palliat Med       Date:  2013-08-15       Impact factor: 2.947

Review 2.  Lost but making progress--Where will new analgesic drugs come from?

Authors:  David Borsook; Richard Hargreaves; Chas Bountra; Frank Porreca
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

3.  Effects of pregabalin on acute herpetic pain and postherpetic neuralgia incidence.

Authors:  Nevenka Krcevski Skvarc; Mirt Kamenik
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

Review 4.  Postherpetic neuralgia: from preclinical models to the clinic.

Authors:  Ada Delaney; Lesley A Colvin; Marie T Fallon; Robert G Dalziel; Rory Mitchell; Susan M Fleetwood-Walker
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

5.  Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy.

Authors:  Giustino Parruti; Monica Tontodonati; Cristina Rebuzzi; Ennio Polilli; Federica Sozio; Augusta Consorte; Adriana Agostinone; Francesco Di Masi; Gabriele Congedo; Domenico D'Antonio; Carla Granchelli; Claudio D'Amario; Carlo Carunchio; Lucio Pippa; Lamberto Manzoli; Antonio Volpi
Journal:  BMC Med       Date:  2010-10-11       Impact factor: 8.775

6.  Acupuncture for the treatment of severe acute pain in herpes zoster: results of a nested, open-label, randomized trial in the VZV Pain Study.

Authors:  Tamara Ursini; Monica Tontodonati; Lamberto Manzoli; Ennio Polilli; Cristina Rebuzzi; Gabriele Congedo; Sonia Di Profio; Patrizia Marani Toro; Augusta Consorte; Giuseppina Placido; Stefano Laganà; Claudio D'Amario; Carla Granchelli; Giustino Parruti; Lucio Pippa
Journal:  BMC Complement Altern Med       Date:  2011-06-05       Impact factor: 3.659

Review 7.  The IASP classification of chronic pain for ICD-11: chronic neuropathic pain.

Authors:  Joachim Scholz; Nanna B Finnerup; Nadine Attal; Qasim Aziz; Ralf Baron; Michael I Bennett; Rafael Benoliel; Milton Cohen; Giorgio Cruccu; Karen D Davis; Stefan Evers; Michael First; Maria Adele Giamberardino; Per Hansson; Stein Kaasa; Beatrice Korwisi; Eva Kosek; Patricia Lavand'homme; Michael Nicholas; Turo Nurmikko; Serge Perrot; Srinivasa N Raja; Andrew S C Rice; Michael C Rowbotham; Stephan Schug; David M Simpson; Blair H Smith; Peter Svensson; Johan W S Vlaeyen; Shuu-Jiun Wang; Antonia Barke; Winfried Rief; Rolf-Detlef Treede
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

Review 8.  Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment.

Authors:  Young Hoon Jeon
Journal:  Korean J Pain       Date:  2015-07-01

9.  Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.

Authors:  Emmanuelle Préaud; Mathieu Uhart; Katharina Böhm; Pamela Aidelsburger; Delphine Anger; Florence Bianic; Nathalie Largeron
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

10.  Post-herpetic neuralgia.

Authors:  Monica Tontodonati; Tamara Ursini; Ennio Polilli; Francesco Vadini; Francesco Di Masi; Damiano Volpone; Giustino Parruti
Journal:  Int J Gen Med       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.